Provivi has raised $85m in Series C funding, enabling it to scale production of pheromone-based pesticides that can discriminate between beneficial insects and harmful ones. The company's patented production methods enable a step change in the cost of manufacturing pheromones. In an interview with TechCrunch, CEO David Viniar said he was "blown away" by the amount of interest from investors for his new product.
Provivi has raised $85m in Series C funding, enabling it to scale production of pheromone-based pesticides that can discriminate between beneficial insects and harmful ones. The company's patented production methods enable a step change in the cost of manufacturing pheromones. The funding round was co-led by Pontifax Global Food and Agriculture Fund and included new and existing investors.